In human Burkitt's lymphomas and murine plasmacyto mas, one c-myc allele becomes juxtaposed to immuno globulin sequences through a reciprocal 5' -> 5' chromo somal translocation (for review, see Cory 1986; Magrath 1990; Spencer and Groudine 1991) . The rearranged c-myc allele is transcriptionally active in these cell types, whereas the germ-line c-myc allele is silenced, as it is in normal mature B cells (Bernard et al. 1983; Nishikura et al. 1983 ). In addition, c-myc promoter usage and transcriptional elongation are altered in those trans locations in which the first c-myc exon remains intact (Taub et al. 1984; Denny et al. 1985; Bentley and Grou dine 1986; Eick and Bomkamm 1989) . These observa tions have led to the hypothesis that sequences present in the immunoglobulin locus that become linked to c-myc by translocation maintain c-myc expression and influence c-myc initiation and transcription in these cells. In translocations between c-myc and the immimoglobulin heavy-chain locus [human t(8;14) and mouse t(15;12)], the breakpoints involved on both chromo somes are highly variable. As a result, the well-described immunoglobulin heavy chain intron enhancer, E|x, be comes linked in cis to c-myc only in about half of Bur kitt's lymphomas and in none of the described murine plasmacytomas (Cory 1986 ), suggesting the presence of an additional sequence(s) in the immunoglobulin locus capable of driving c-myc expression. Further evidence for the presence of immunoglobulin heavy-chain regulatory sequences besides E|x include the identification of mouse myeloma cell lines that produce functional IgH despite having deleted Efx (Klein et al. 1984; Aguilera et al. 1985; Eckhardt and Birshtein 1985) . In addition, a natural de letion of sequences 3' to the Ca gene has been shown to reduce IgH transcription in a line that retains EJJL (Gregor and Morrison 1986) .
Recently, a late B cell-specific transcriptional en-hancer has been identified both in the rat (Pettersson et al. 1990 ) and the mouse IgH loci (Dariavach et al. 1991; Lieberson et al. 1991) , located 25 and 16 kb downstream of the Ca-coding region, respectively (3' Ca enhancer). Targeted deletion of this element in embryonic stem (ES) cells resulted in defects in germ-line transcription and secretion of specific immimoglobulin isotypes (Cogne et al. 1994) . A third, less active enhancer in the IgH locus also has been identified immediately 3' of the murine Ca gene (Ca 3' enhancer) (Matthias and Baltimore 1993) . Despite the strong transient enhancer activity re ported for the rat 3' Ca enhancer in plasmacytomas (Pet tersson et al. 1990 ), this enhancer had no significant ef fect on c-myc transcription in a stably transfected plas macytoma line, unpubl) . Our search for additional regulatory elements in the 3' Ca region that might deregulate the expression of translo cated c-myc alleles has revealed a series of four tissuespecific and stage-specific DNase I hypersensitive sites (HSs) located 3' of the Ca-coding gene, consistent with the recent findings of Giarmini et al. (1993) . The two DNase I HSs most 5' in the series (HSl and HS2, our nomenclature) map to the 3' Ca enhancer, whereas two additional sites are located -13 kb (HS3) and 17 kb (HS4) farther 3' of this enhancer.
The presence of these four tissue-specific and cell stage-specific DNase I sites is reminiscent of the locus control region (LCR) responsible for the tissue-and stage-specific expression of the p-like globin genes (For rester et al. 1990; Townes and Behringer 1990) . The P-globin LCR influences chromatin structure and timing of DNA replication over at least 200 kb and functions as a transcriptional enhancer over a distance of ~75 kb. In transfection and transgenic assays, the LCR confers tis sue-specific, high-level and position-independent expres sion to CIS-linked genes (Blom van Assendelft et al. 1989; Grosveld et al. 1987) . These are characteristics that might be predicted for a regulatory element/domain in the IgH chain locus that effectively controls, over a large and variable distance, c-myc expression in c-myc/IgH translocations. Because the DNA region spanned by the four 3' Ca HSs is always linked to c-myc in plasmacy toma associated translocations, we wondered if these sites might play a role in controlling c-myc expression in these myelomas through an LCR-like mechanism.
In this report, we present the sequence of, and describe the enhancer activity associated with, DNA fragments comprising the two 3'-most distal IgH locus HSs men tioned above. Further, we show that a combination of the four DNase I HSs can affect c-myc transcription in stable transfections in Burkitt's lymphoma and plasma cytoma cell lines. Linkage of c-myc to a fragment con taining HSl-4 resulted in a shift of c-myc promoter us age, from the P2 to the PI promoter and increased the RNA polymerase density in 3' regions of the gene. In addition, HSl-4 also conferred position-independent, copy number-dependent expression to linked c-myc genes stably integrated in a plasmacytoma cell line. In combination, these results suggest that the four DNase I HSs 3' to Ca may act as an LCR, deregulating c-myc expression in t(15;12) plasmacytomas, as well as poten tially contributing to aspects of normal IgH chain expres sion such as isotype switching.
Results

Chromatin and sequence analysis of the 3' Ca region
Four tissue-specific and cell stage-specific DNase I HSs map to a region -10-30 kb 3' of the Ca-coding sequence in the mouse IgH locus. Figure lA depicts the relative location of these DNase I HS sites to the IgH intron enhancer and to various plasmacytoma breakpoints mapped in the IgH locus. HSl and 2, (numbered for con venience 5'-»3'), lie within the previously described, late B cell-specific, 3' Ca enhancer. These sites, along with HS3, have been detected in DNA from a number of myeloma cell lines but are absent in DNA preparations from earlier stage B cells, including pre-B and LPS-induced pre-B cells, as well as from non-B cells, including T cells, hematopoietic cells, and fibroblasts. The 3'-most distal site, HS4, has been detected in three pre-B lines tested and, to varying degrees, in different myeloma and plasmacytoma cells, but similar to the other three sites, is limited to cells of the B lineage ( Fig. 1B,C ; Giannini et al. 1993) . To evaluate whether these tissue-and cell stage-specific DNase I HSs comprise an LCR-like ele ment in the IgH locus capable of affecting c-myc tran scription, we cloned DNA regions encompassing each of these sites for use in transient and stable functional as says.
By Southern blot analysis, HS3 mapped to a 1182-bp Xbal-Sau3A fragment. The sequence of this fragment, shown in Figure 2A , contains homologies to many known protein-binding motifs, including a 7 of 8 bp match to the octanucleotide element. Flanking the octamer-binding element are three exact matches to the |xE5 site and close homologies to the ]xEl-and |jLE3-binding motifs. These helix-loop-helix E box proteins have been shown to participate in controlling the specificity and activity of the IgH intron, 3'K and 3'Ca enhancers (Meyer and Neuberger 1989; Beckmann et al. 1990; Pongubala and Atchison 1991; Ruezinsky et al. 1991; Grant et al. 1992 ). In addition, good matches to the SV40 en hancer motifs AP-1, AP-2, and AP-4 are also present.
The 3'-most distal site, HS4, was similarly mapped to a 1381-bp Psfl-Hindlll fragment. The sequence of HS4 is shown in Figure 2B . As observed for the DNA fragment HS3, HS4 contains motifs associated with immunoglob ulin enhancers. Of primary interest is the presence of two octanucleotide elements (7/8 and 8/8 match to con sensus) separated by 120 bp. HS4 also contains numerous sequence similarities to the iiES consensus, as well as a single |jLE3-like motif -420 bp 3' of the two octanucle otide elements. In addition, multiple sequence homolo gies to the AP-1, AP-2, and AP-4 SV40 enhancer sites are present.
Thus, DNA sequences that comprise HS3 and HS4 contain potential protein-binding motifs for many of the trans-activators known to regulate the IgH intron, 3' Ca . (B,C) Nuclei from different stage B cell lines were treated with increasing amounts of DNase I before isolation of genomic DNA (see Materials and methods). Southern blots of £coRI-digested DNA from the pre-B line 18-81 and the late B plasmacytoma line MPC-11 were probed with a 500-bp EcoKL-Xbal fragment (indicated in A). This probe hybridizes to a unique £coRI fragment of an approximate size of 26 kb in untreated EcoRI-digested DNA. In 18-81 DNA (B), a single subfragment of 15 kb (HS4) is seen in addition to the 26-kb parental band, whereas MPC-11 DNA (C) contains the 15-kb subfragment (HS4) along with a more prominent 11-kb subband (HS3). Similar analysis of TEPC 1165 plasmacytoma DNA revealed identical subfragments as in C. and 3'K light-chain enhancers. Although the functional significance of these motifs in HSS and HS4 has not yet been demonstrated, the apparent clustering of binding sites for factors involved in immunoglobulin expression in these HS fragments may suggest a role for these se quences in heavy-chain gene expression.
HSl-4 enhance promoter activity in transient assays in plasmacytoma cells
To determine whether DNA fragments containing HSS and HS4 represent elements that might contribute to a LCR function in c-myc deregulation, we first evaluated the ability of these DNA fragments to stimulate tran sient transcription of a reporter gene in various cell types. Sequences of DNA included in the four 3' Ca HSs were cloned singly and in combinations upstream of the human growth hormone gene under the control of either the human c-myc promoter (2.5-kb Hindlll-Nael] or the immunoglobulin light-chain promoter, VX.1 (Hagman et al. 1990 ) (Fig. SA) . The orientation of the various HSs relative to each other and to the promoter was chosen to reproduce that found in translocations involving c-myc and the immunoglobulin heavy-chain locus, that is, a 5' -» 5' orientation. As a comparison, we also analyzed the activity of a 1-kb Xbal fragment containing the en hancing and flanking matrix attachment region (MAR) sequences of mouse E|i (Cockerill et al. 1987) . The abil ity of the various HSs to enhance transcription from the c-myc and V\l promoters in different cell types is shown in Figure 4 and summarized in Table 1 . Consistent with previous reports, the S' Ca enhancer (HSl2) increased transcription from both promoters TATCTAGTCC   GGTCTGGGTT  TAATCTTAAT  CCATGGCCTT  CCACCCCTCA  ACAGTAGCTC  CAGCTCAGAG  GAAAAACAAG  CCCCACACTO  CCAGAGGAGA  CCTGCAAAGC  CTCCCAGGGC  TGAGCGAAAG  TGGAATCTTC  GCAAAGGGAC  TGAGGACCAA  AGAACTCAAT  GACCCAGTTG   AAGGOATATT  GGCAGGGATA  TCTGCCAGAA  CTCTCTGGCT  TOGACTTGTT  GGGTOATGGG  TCCAOGTCCC  TOGTTTGGGO  CTGCTTTGAA  TTGCTAATGT  TTGACCCCAG  GAAAAATAGT  TCCCCAGGAT  CTGGGCTTGC  GGGTCACTGT  TGCAGGAATC  GTCTTGTAAA  GCTCCAGGGC  GATGAGGGCC  TTAGAGCCGG   GCGCCAATAC  AACTCTCCTT  TAGCTGTGTG  GACAGCCCTT  CTCAlTGQGA  GGr rCGGCCC  AGGCCC-«C«T  CALCTGTCCT  TGTTTCAOCA  GAACATCCCT  ATAGAOATCC  ATCTACAAOC  GCTCACCCCA  TTTGTCTCCA  CCCAGTTGCA  CCCTGTAGGG  ATACCACTGA  CAGTGTTGGT  AGGGCCCAAT  AGCTCAATGA   ATCTGIAGTG  TCTGCATCTC  GCCTTGGGTG  GACTCTCGAT  CAGAACATGG  TCCTCAGCCC  Cf<»lCCTGGTrC  GAGAAAGGCT tested in a late B cell line, plasmacytoma TEPC 1165 ( Fig. 4A,B) . In TEPC 1165, the 3' Ca enhancer increased growth hormone transcription from the c-myc promoter > 100-fold, -10% of the activity shown by the E|x en hancer. DNA fragments comprising HS3 or HS4 in creased transcription from the c-myc promoter 40-fold in the 1165 cells, approximately one-third the level of the 3' Ca enhancer. Significant activation of transcription, approximating that induced by the E|x enhancer, resulted when various combinations of the same HS-containing fragments were placed upstream of the c-myc promoter. The combination of HS1234 activated growth hormone transcription 1000-fold above an enhancerless control, suggesting a strong synergistic interaction between fac tors binding to these sites. Synergistic transcriptional ac tivation was exhibited by other combinations of HS frag ments as well. HS123-, HS124-, and HS34-containing constructs gave 710-, 2 70-, and 520-fold as much growth hormone, respectively, as the promoter only construct in 1165 cells. Constructs containing two copies of HS3 (HS3,3) or HS4 (HS4,4) exhibited synergistic transcrip tional activation in 1165 cells, whereas an additive effect was seen with two copies of HS12 (HS12,12), the 3' Ca enhancer. A similar pattern of c-myc promoter activa tion was observed when the same constructs were tran siently expressed in a second plasmacytoma cell line, MPC-11 (data not shown).
To determine whether the transcriptional enhancer activity associated with various HS-site combinations described above was specific to the c-myc promoter, we replaced the c-myc promoter in the growth hormone constructs with an immunoglobulin promoter VXl. Transient growth hormone assays with the VXl con structs in 1165 plasmacytoma cells demonstrated that combinations of HS-containing fragments synergistically activated transcription in a pattern similar to that observed using the c-myc promoter ( Fig. 4B ; Table 1 ). Maximal activation of the VXl promoter, resulting in a 690-fold increase in reporter expression compared with an enhancerless construct, was observed with a con struct containing HS1234 . DNA fragments containing combinations of HS123, HS124, and HS34 enhanced ex pression 220-to 340-fold. As with the c-myc promoter constructs, HS12, HS3, and HS4 activated the VXl pro moter constructs to a much lower extent when present individually. The ability of these individual sites to en hance VXl promoter transcription relative to each other differed from that observed with the c-myc promoter. 
HS4, but not HSl-3, enhances activity in pre-B cells
In the pre-B lymphocyte cell line 18-81, only HS4 is hypersensitive to DNase I digestion (Fig. IB) . To deter mine whether HS4 is capable of enhancing transcription in pre-B cells, we repeated our transient transcription analysis in 18-81 cells. As shown in Figure 4C and sum marized in Table 1 , the DNA fragment containing HS4 does increase transcription from the c-myc promoter fourfold over the c-myc enhancerless control in 18-81 cells. A more dramatic enhancement of 30-fold was ob served with two copies of HS4, again indicating that HS4 can bind factors that synergize with each other to acti vate transcription. As might be expected from the DNase I mapping data, neither HS12 nor HSS stimulated tran scription in 18-81 cells, even when present in multiple copies. Combinations of HS124, HS34, and HS1234 stimulated growth hormone levels to that equaling HS4 alone.
In the pre-B 18-81 cell line, the enhancerless VXl growth-hormone construct demonstrated low basal ac tivity, and no significant increase in transcription was observed by addition of fragments containing only HSI2 or HSS (Fig. 4D and Table 1 ). In contrast, and as observed for the c-myc promoter, HS4 enhanced VXl promoterdriven growth hormone levels equally well by itself and in combination with HSS and HS12S, increasing tran scription 15-fold above an enhancerless control. The VXl promoter construct containing HS12 in addition to HS4, however, was only half as active as HS4 alone (8-vs. 15-fold induction). The apparent inhibitory effect of HS12 on HS4 in 1881 cells was not observed in the c-myc promoter assays and may reflect a specific negative in teraction between a protein binding to HS12 and the VXl promoter.
The enhancer activity of HSl-4 is specific to cells of the B lineage
The B cell specificity of the HSl-4 enhancing fragments was investigated by determining their ability to stimu late growth hormone expression in L-cells, a mouse fi broblast cell line. Although the VXl promoter itself di rected considerable transcription in these cells, none of the HSl-4 fragments increased this basal transcription ( Fig. 4E ; Table 1 ). Some repression of growth hormone expression was observed in constructs containing the 18-81 Pre-B line 1 0.8 ± 0.2 0.7 ± 0.3 3.6 ± 0.5 0.7 ± 0.2 4.6 ± 0.9 6.4 ± 0.9 6.9 ± 1.1 1.6 ± 0.3 0.7 ±0.1 29.8 ± 1.7
6.2 ± 1.6 1 1.1 ±0.2 1.0 ±0.1 15.0 ± 1.4 2.1 ± 0.3 8.0 ± 1.5 13.2 ± 2.8 11.4 ± 1.9 18.5 ±3. consistent with the lack of detectable hypersensitivity in the 3' Ca region in these cells.
HSl-4 confer position-independent and copy numberdependent expression and a shift in promoter usage to a cis-linked c-myc gene in a plasmacytoma cell line
As discussed in the introductory section, reciprocal chro mosomal translocations between a c-myc allele and one of the immunoglobulin loci results in the elevated, de regulated expression of the translocated allele in mature B cells as well as an increase in usage of the normally minor promoter, PI. When normal or mutated c-myc genes are transfected into mouse fibroblasts (Richman and Hayday 1989) , B-lineage cells (Spencer et al. 1990) , and human Burkitt's lymphoma cells (Polack et al. 1991) , low expression initiating predominately from the P2 promoter is observed. In addition, few of the trans fected genes are expressed, suggesting that the position of integration may influence the expression of these c-myc genes. Presumably then, sequences in the immu noglobulin locus that are juxtaposed to the translocated c-myc allele and that have not been included in the transfected c-myc constructs, are required to effect c-myc deregulation. Our findings, in transient assays, of a synergistic activation of the c-myc promoter by HS1234 led us to examine whether these sequences could overcome position effects and deregulate c-myc expression in stable transfections.
1165 cells were co-transfected with RSV-neo and ei ther c-myc or HS1234 c-myc (Fig. 3A,B) , and individual clones were propagated following selection with G418. DNA copy numbers were determined by Southern blot analysis, and RNA expression was analyzed by SI pro tection with end-labeled probes specific for human c-myc and mouse glyceraldehyde-3-phosphate dehydro genase (GAPDH) transcripts. The expression of c-myc and HS1234 c-myc-containing 1165 clones is shown in Figure 5A . The transfected 1165 clones contained from 1 to 28 and 3 to 14 copies of c-myc and HS1234 c-myc, respectively (data not shown). Only one of eight clones positive for the control c-myc-transfected DNA showed detectable c-myc transcription (clone 1.2, having nine copies), whereas all 16 HS1234 c-myc-positive clones ex pressed high levels of human c-myc. This result suggests that the DNA fragment containing HS1234 is sufficient to confer position-independent expression to the linked c-myc gene. In addition, clones containing the HS1234 c-myc construct expressed the transfected c-myc gene in a copy number-dependent manner (Fig. 5B) .
Cis linkage of HS1234 to c-myc also affected both the overall level of transfected gene expression and the ratio of PI-to P2-initiated transcripts. Total expression of Pland P2-initiated transcripts per copy of integrated DNA, relative to an internal control transcript (GAPDH), was 10-to 100-fold higher in clones containing HS1234 com pared with clone 1.2, with 12 of 16 clones demonstrating 20-to 30-fold higher expression per copy. In addition, 15/16 of the HS1234 c-myc clones demonstrated a PI/P2 ratio between 0.8 and 1.2, whereas c-myc clone 1.2 showed a P1/P2 ratio of 0.4.
In summary, our findings in stably transfected 1165 plasmacytoma cells indicate that linkage of HS1234 to human c-myc results in enhanced c-myc transcription, distinguished by increased utilization of the normally minor PI promoter and by apparent position-indepen dent, copy number-dependent expression of the trans fected gene. In combination, these results suggest that HS1234 comprise an LCR-like element that may be re sponsible for the deregulation of the translocated c-myc allele in plasmacytomas and Burkitt's lymphomas.
The activity of murine HSl-4 is conserved in a human Burkitt's lymphoma cell line
Because many of the aberrant features of c-myc expres sion observed in murine plasmacytomas and human Bur kitt's lymphomas are similar, we were curious whether the murine 3' Ca HS1234 could also influence c-myc transcription in a human Burkitt's lymphoma cell line. Transient expression assays performed in the EpsteinBarr virus-positive Raji Burkitt's lymphoma line with the c-myc growth-hormone constructs described above revealed that the activity of the mouse-derived HS frag ments is conserved in the human Burkitt's lymphoma background. Transcription from the c-myc promoter was increased 11-fold by the addition of HS1234, whereas HS12 increased reporter gene expression only slightly in Raji cells, about twofold above an enhancerless control construct (data not shown). To compare the effects of HS12 to HS1234 and E|x on stable c-myc transcription in a Burkitt's lymphoma background, we transfected Raji cells with various c-myc constructs that had been cloned into the EBV-derived episomal vector, pHEBO (Sugden et al. 1985) , shown in Figure 3A and B. Because the stably transfected c-myc genes on the episome do not become integrated into cel lular DNA, the control c-myc genes are not subject to position effects. Thus, in contrast to the low frequency of active control c-myc integrants obtained by conven tional stable transfection (see above), the episome sys tem offers the advantage of providing large numbers of active control c-myc templates. This permits direct com parisons of expression and promoter usage between con trol and HS-driven c-myc constructs in the absence of position effects (Polack et al. 1991) . RNA from pools of stably transfected Raji cells was analyzed for c-myc ex pression by SI protection (Fig. 6A) . Because the translo cated c-myc allele in Raji has a large deletion at the end of exon 1 (Rabbitts et al. 1983 ), our SI probe did not protect transcripts from this endogenous allele, allowing us to compare c-myc expression originating from the pHEBO constructs.
Consistent with previous reports that unrearranged c-myc alleles in Burkitt's lymphoma and plasmacytoma cells are generally inactive, we detected few PI and P2 transcripts in imtransfected Raji cells (Fig. 6A) . When c-myc was expressed either without an additional en hancer or when linked to the mouse 3' Ca enhancer {HS12), transcripts initiated at P2 were predominant, re sulting in a P1/P2 ratio of 0.2. In contrast, three inde pendent pools of HS1234 c-myc transfectants exhibited elevated P1/P2 ratios^l.O, whereas Efx increased the PI/ P2 ratio to 0.8.
As was observed in 1165 cells, per copy expression of c-myc in Raji pools containing HS1234 c-myc was sig nificantly higher, 40-fold, than that in pools containing the control c-myc construct. Linkage of the E|x enhancer or HS12 (3' Ca enhancer) to c-myc increased per copy expression to a lesser degree, with E|JL pools expressing 12-fold and HS12 pools expressing 3-fold more c-myc transcripts per DNA copy. A possible caveat in the per copy expression analysis of c-myc-and HS1234 c-myccontaining pools is the finding that episome copy num bers varied significantly between these pools. The copy number of three Raji pools independently transfected with the HS1234 c-myc construct was 15-fold lower than two pools expressing the control c-myc plasmid, whereas DNA copy numbers for the E|x and HS12 pools were approximately half that of the control c-myc pools (see legend to Fig. 6 ). Thus, although the enhancement of c-myc expression by HS1234 in the stable Raji transfec tants is consistent with the transient data, we cannot rule out the formal possibility that cells with high epi- [A] Total RNA isolated from stable pools was analyzed in a SI nuclease assay with an end-labeled single-stranded probe specific for c-myc transcripts originating from transfected DNAs. A diagram of human c-myc exon 1 is shown along with the deletion (open box), at the end of exon 1 present in the Raji-translocated c-myc allele. The location of the SI probe and size of protected PI-and P2-initiated fragments are indicated. As an internal control, a probe specific for human GAPDH was also included in the assays. Transcripts initiating from PI and P2 are indicated, and the signal from protected human GAPDH is shown. SI analysis of three independently transfected pools is presented for the HS1234 c-myc pHEBO construct.
[B] Per copy expression of the stably transfected Raji pools was calculated as total P1-I-P2 expression divided by transfected DNA copy number as determined by Southern blot analysis (data not shown). Episomal copy numbers of the various pools were estimated to be c-myc pools A,B= 190 and 126; HS12 pool = 95, HS1234 pools A,B,C= 12,11 and 8; Ej j L pool = 69. some numbers may transcribe any one template less ef ficiently than cells with fewer episome numbers.
The cause of the relatively low number of stable episomes present in HS1234 c-myc containing pools is un clear. Because EJJL myc-containing pools transcribed more c-myc per cell than HS1234 c-myc pools, (based on relative levels of GAPDH control transcripts), a selection against high c-myc expression in HS1234 c-myc pools seems imlikely. Sequences within the HS1234 DNA fragment could inhibit transcription directly, by interfer ing with vector origin function, or indirectly, by com prising a competing origin in the plasmid. Alternatively, the high c-myc transcription from HS1234 c-myc episomes might itself inhibit replication of these episomes. Support for the latter hypothesis comes from a recent study in human cells in which high transcriptional ac tivity of an autonomously replicating plasmid decreased the frequency of replication of that plasmid (Haase et al. 1994) . The reduced episome numbers observed in HS1234 c-myc transfectants^ then, could be a result of a highly active c-myc promoter in these constructs.
HSl-4 alters the distribution of RNA polymerase II complexes in the c-myc gene in plasmacytoma and Burkitt's lymphoma cells
Nuclear run-on analyses of normal c-myc genes have demonstrated that a conditional elongation block within exon 1 is a major mode of regulation of this gene (Bentley and Groudine 1986; Krumm et al. 1992; Strobl and Eick 1992) . Previous nuclear run-on analyses of c-myc tran scripts in Burkitt's lymphoma cells have revealed a con stitutive increase in polymerase density in the 3' region of the gene (Bentley and Groudine 1986; Cesarman et al. 1987; Strobl et al. 1993) , indicating an abrogation of this control mechanism. Because linkage of HS1234 to c-myc was observed to affect many aspects of the gene's tran scription, we sought to determine whether HS1234 di rected an alteration in polymerase distribution along the transfected c-myc gene. Nuclear run-on transcription experiments were per formed on both plasmacytoma 1165 clones containing integrated c-myc or HS1234 c-myc and on pools of trans fected Raji cells containing episomes with c-myc or HS1234 c-myc with exon 1-and intron 1-specific probes described previously (Spencer et al. 1990) (Fig. 7A) . The hybridization signals, quantified by Phosphorlmager, were corrected for the U content of each probe and were normalized to the total exon 1 -I-intron 1 signal to give a relative distribution of polymerases within these re gions of the gene. Untransfected 1165 cells exhibited lit tle detectable c-myc signal demonstrating the lack of cross-hybridization between murine c-myc and our hu man probes (Fig. 7B) . Analysis of 1165 clone 1.2, which expresses human c-myc, revealed a disproportionately low level of polymerase complexes in intron 1 compared with exon 1 as indicated by a corrected intron 1 to exon 1 signal ratio of 0.13 (Fig. 7C) . The intron 1/exon 1 ratio was nearly six-fold higher in two different 1165 clones containing HS1234-linked c-myc, suggesting that signif icantly more polymerase complexes had transcribed far ther 3' into the transfected gene in these cells.
Similar analyses of the Raji-transfected pools revealed that murine HS1234 could also affect polymerase distri bution along c-myc in a Burkitt's lymphoma back ground. Transcription of endogenous Raji c-myc was low compared with the pools containing the transfected c-myc episomes and the ratio of intron 1 to exon 1 signal was 0.30, reflecting the absence of a significant disparity in polymerase density in the 5' and 3' regions of the gene. (Fig. 7B,C) . Consistent with the above data from 1165 clones, c-myc-transfected Raji pools demonstrated a very low intron 1/exon 1 signal ratio of 0.02, whereas HS1234 c-myc Raji pools exhibited an eightfold increase in this ratio. In addition, linkage of the E|x enhancer to c-myc resulted in a fivefold increase in polymerase den sity in intron 1 (data not shown). These results suggest that HS1234 and the E|x enhancer augment c-myc tran scription, at least in part, by abrogation of transcriptional elongation control mechanisms.
Discussion
HS3 and HS4 define novel regulatory elements in the 3' Ca IgH region
Several lines of evidence have suggested the presence of a regulatory element/domain in the region 3' of the IgH Ca-coding genes. Naturally occurring deletions of the intronic enhancer, EJJL, do not impair heavy-chain expres sion in a number of characterized myeloma cell lines, whereas a large deletion of sequences 3' to the Ca gene does reduce heavy-chain transcription. In addition, the deregulated expression of c-myc alleles translocated into the IgH locus cannot be attributed simply to E[JL, as this enhancer is not linked to c-myc in murine plasmacyto mas and is only occasionally linked to c-myc in human Burkitt's lymphomas. The recent discovery and func tional analyses of two enhancers located 3' of Ca (3' Ca enhancer, corresponding to HS12 described above, and Ca 3' enhancer) support a role for the 3' Ca region se quences in the regulation of normal IgH gene expression, as well as in the deregulation of c-myc genes that be come cis linked through genomic rearrangement. The results presented in this report demonstrate that two ad ditional elements (HS3 and HS4), located 13 and 17 kb 3' of the 3' Ca enhancer, likely contribute to the regulatory potential of the 3' Ca region.
Sequence analysis of the murine 3' Ca enhancer has revealed the presence of multiple protein-binding motifs which, through deletion experiments, have been shown to act synergistically to impart the enhancer with its transcriptional activity and tissue specificity (Grant et al. 1992) . Similarly, HS3 and HS4 contain multiple bind ing sites for transcriptional activators commonly associ ated with immimoglobulin enhancers, and, like HS12 (3' Ca enhancer), these elements activate the c-myc and VXl promoters in plasmacytoma cell transient assays. In combination, HS1234 directed a highly synergistic tran scriptional response, equaling that induced by EJJL, on both the c-myc and V\l promoters in plasmacytoma cell lines. The actual mechanism of the observed synergies is unknown. Multiple interactions are likely occurring be tween activating factors and some component! s) of the basic transcriptional machinery, either simultaneously or at distinct stages of preinitiation complex assembly (Lin et al. 1990; Choy and Green 1993; Herschlag and Johnson 1993) .
The DNA encompassing HS4 as well as HS12 and HS3 has been determined to be hypermethylated at the pre-B stage, leading to the suggestion that a DNA-binding pro tein specific for methylated DNA might interact with the 3' Ca region to help sequester functional elements (Giannini et al. 1993) . Alternatively, the DNA sequences comprising HS4 might bind positive acting factors at the pre-B stage despite being surrounded by methylated chromatin. In the latter scenario, a methylated DNAbinding protein might create an open window for a transacting factor to bind in an otherwise inaccessible region (Gross and Garrard 1988) . In transient assays, we ob served that HS4 can enhance transcription from both the c-myc and V\l promoters in pre-B cells, suggesting that this region has the potential to contribute positively to transcription. Concordant with the DNase I HS data, HS12 and HS3 had no enhancer activity in pre-B cells.
Interestingly, the enhancing potential of HS4 on the VX.1 promoter, but not on the c-myc promoter, appeared to be influenced by the presence of HS12 in pre-B cells. HS12, the 3' Ca enhancer, has been shown to bind NF-HB (BSAP), a negative regulatory protein expressed in pro-, pre-and mature B cells (Singh and Birshtein 1993) . Although we observed no reduction in the HS4 enhancer potential on the c-myc promoter by addition of HSI2, this addition did reduce the activation from VXl by 50%. This result suggests that promoter specific interactions between transcription complexes and proteins bound to upstream elements present in HSl-4 could add to the complexity of the potential of HSl^ to regulate normal IgH gene expression. Also in agreement with DNase I mapping data, none of the HSI-4 elements demonstrated enhancer activity in a fibroblast line, either alone or in combination. Motifs for several ubiquitously expressed helix-loop-helix DNAbinding proteins are present in each HS fragment, sug gesting that the inactivity of HSl-4 in non-B cells could be mediated either through cell type-specific repressors or through the binding of HLH dimers having different composition and activity than those found in cells of the B lineage (Imler et al. 1987; Pongubala and Atchison 1991) .
HS1234is sufficient to deregulate c-myc transcription
In a recent study, linkage of c-myc to sequences encom passing the human IgK locus containing MAR, intron enhancer, constant K gene, and 3' enhancer resulted in increased c-myc expression and a promoter shift from P2 to PI from constructs stably transfected into Raji cells . The effects on c-myc transcription were dependent on an interaction between these ele ments, as neither enhancer alone was capable of induc ing the altered pattern of c-myc expression. These find ings are consistent with the observation that all translo cations between c-myc and the human K light-chain locus, t(2;8), result in colocalization of the 3' and intron enhancers with c-myc on one of the rearranged chromo somes. In contrast, chromosomal rearrangements be tween c-myc and the IgH locus generally segregate E| JL and the 3' regulatory region, HSl-4, to different translo cation products. Consistent with these findings, we have demonstrated that linkage of HS1234 to c-myc deregu lates c-myc expression without the requirement of an additional interaction with the intron enhancer E|x. In stable transfection assays, sequences comprising HSI234 are sufficient to direct high level expression, a P2 to PI promoter shift, and the deregulation of an important control of c-myc expression, transcriptional elongation. We are currently evaluating the contribution of individ ual HS elements to various aspects of the HS1234 c-myc expression phenotype.
In Raji Burkitt's lymphoma cells, linkage of the E|x enhancer to c-myc resulted in many of the same changes in c-myc transcription as those induced by HS1234, in cluding an increase in the elongation efficiency of RNA polymerase 11 through the c-myc gene. Thus, it is possi ble that various classes of enhancers, including HS1234 and E|x, may increase gene expression, at least in part, by contributing to the assembly of RNA transcription com plexes that are highly efficient in elongation (for review, see Krumm et al. 1993; Yankulov et al. 1994) .
HS1234 functions as an LCR
HSI234 linked c-myc constructs are expressed in a plas macytoma line at levels proportional to DNA copy num ber, c-myc expression was observed in all subclones con taining HS1234 constructs, but in only one subclone containing the control c-myc gene, suggesting that HS1234 either can confer position-independent expres-
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Cold Spring Harbor Laboratory Press on August 14, 2017 -Published by genesdev.cshlp.org Downloaded from sion to a linked gene in these cells, or can overcome the postulated allelic exclusion of unrearranged c-myc genes in plasmacytoma cells. The pleiotropic effects of HS1234 on c-myc expression are reminiscent of a class of tran scriptional regulatory elements referred to as LCRs. LCRs have been defined functionally by their ability to direct tissue-specific expression of linked genes in a po sition independent, copy number dependent maimer. The p-globin LCR, which regulates the tissue and tem poral expression of the p-like globin genes throughout development, influences both the chromatin organiza tion of the globin locus and the expression of stage-spe cific globin gene promoters. By analogy, an LCR-like el ement composed of sequences spanning HSl-4 in the IgH 3' Ca region may function in normal B cells to main tain the IgH constant genes in a transcriptionally com petent chromatin structure, as well as to regulate the class switching of constant genes through interactions with their specific promoters.
Recently, it was reported that the targeted deletion of HS12 (3' Ca enhancer) and concomitant insertion of a selectable marker gene into this region resulted in par ticular class switching defects of IgH isotypes (Cogne et al. 1994) . It is not clear whether these defects are the result of the deletion of HS12 per se or of a selectable marker-mediated promoter/enhancer competition for other elements in the 3' Ca region, as has been observed for targeted insertions in the p-globin LCR (Kim et al. 1992) . Nevertheless, the fact that only a subset of iso types was affected by the deletion/insertion event is con sistent with a model in which all four HSs in the 3' Ca region interact to maintain a chromatin domain permis sive for IgH constant gene expression and suggests some specificity or competition in interactions between vari ous constant gene promoters and 3' regulatory elements. Additional targeted deletion studies will be required to further delineate the role of individual elements in the 3' Ca region in regulating the tissue-and stage-specific ex pression of genes in the IgH locus.
Materials and methods
DNase I hypersensitive site assays
The isolation and DNase I treatment of nuclei were performed as described (Forrester et al. 1990 ). Briefly, nuclei were incu bated with 0.01-15 mg/ml of DNase I at 37°C for 5-15 min before being lysed and treated with proteinase K in 2x stop buffer (0.6 M NaCl, 20 mM Tris-HCl (pH 7.6), 10 mM EDTA, 1% SDS). DNA was precipitated, treated with RNase A, phenol/ chloroform extracted, and reprecipitated prior to restriction en zyme digestion and southern blot analysis. Preliminary charac terization of HS12 was done on Xbal-digested DNA with the 500-bp EcoKL-Xbal fragment indicated in Figure 1 as a Southern blot hybridization probe. HS3 and HS4 were initially mapped with the same probe on blots of EcoRI-digested DNA.
HS cloning and sequencing
Approximately 30 kb of mouse genomic sequence spanning the 3' Ca enhancer was cloned in sequential steps from a phage library of partially digested 129 ES genomic DNA (Stratagene).
Initial hybridization screening was done with a 1.1-kb Stul frag ment from the rat 3' Ca region (gift from Dr. M. Neuberger). Library screening and subsequent mapping of positive phage were performed by use of standard molecular biology tech niques (Ausubel et al. 1989) . Southern blot analyses of MPC-11 DNA that had been DNase 1-treated and restriction digested with Xbal and Hindlll localized HS3 to a 1182-bp Xbal-Sau3A fragment (by use of 280-bp Hindlll-BamHl fragment as a hy bridization probe) and HS4 to a 1381-bp Pstl-Hindlll fragment (using the 1182-bp Xbal-SauSA fragment as a hybridization probe). These fragments were subcloned from a positive phage into pBSKSII -I-vector (Stratagene) for propagation and were se quenced by the dideoxy chain termination method with the Sequenase version 2.0 sequencing kit and protocol.
Plasmid constructs
Mouse genomic DNA fragments containing HSl-^ were subcloned from positive phage isolated from a 129 ES genomic li brary. HSl and HS2 lie within the 3' Ca enhancer (Giannini et al. 1993) and are contained in a 4-kb Xbal fragment. HS3 maps to a 1182-bp Xbal-Sau3A fragment that was subcloned as a slightly larger Xbal-Sall fragment {Sail site was picked up from the phage poly linker). HS4 is contained in a 1381-bp PstlHindlll fragment. Restriction fragments encompassing the in dividual HS sites were subcloned singly and in combinations into the pBSKSll + vector while maintaining their genomic or der and 5'-3' orientation.
The human growth hormone (HGH) constructs used in tran sient assays were derived from pOGH, a pUC12 vector contain ing a promoterless HGH gene. A 2.5-kb Hindlll-N^el fragment encoding the human c-myc upstream region, promoter and first half of exon 1 was cloned 5' of the HGH gene to create the enhancerless control plasmid, c-mycGH. Similarly, a 161-bp Sacl-Sspl fragment comprising the VXl promoter (Hagman et al. 1990 ) was used to generate VX.1GH. Various individual and combined HS fragments were then cloned immediately 5' to the c-myc and VXl promoters by use of restriction sites acquired from the pBSKSII + vector and those present in the polylinker of pOGH. The orientation of the HS fragments to the c-myc and VX.1 promoters was 5' ^ 5' (i.e., the c-myc Hindlll 5' end ad joined the 5'-most Xbal end of the HSl2 fragment in HS1234). A 1-kb fragment containing the murine E| JL enhancer and flank ing MAR sequences (Cockerill et al. 1987 ) was also cloned up stream of the two promoters to generate E^,-c-mycGH and E|x-VXIGH.
The HSl234 c-myc construct used to stably transfect mouse plasmacytoma 1165 cells was made by initially subcloning a 8.1-kb HmdIII-£coRI fragment containing human c-myc 5'-untranscribed and coding sequences into the vector pBSKSII + at the Hindlll and £coRI sites. A 6.5-kb fragment generated by Notl digestion, followed by nucleotide fill-in and Sail digestion, comprising HSl-4 was then inserted immediately upstream of c-myc into a site created by Hindlll digestion, followed by fill-in and Sail digestion.
The episomal vector, pHEBO, contains the EBV origin of la tent replication oriP and the hygromycin B resistance gene (Sugden et al. 1985) . The 8.1-kb HindlII-£coRI c-myc-encoding frag ment was cloned into Hindlll and BamHl sites, placing c-myc 5' to oriP. Fragments containing HS12, HS1234, and E^JL were then inserted immediately upstream of c-myc in pHEBO, by use of restriction sites acquired from the corresponding c-mycGH transient constructs.
Cell lines and transfections
The Raji Burkitt's lymphoma cell line (Rabbitts et al. 1983) , obtained from Dr. R. Baer (University of Texas), and the mouse MPC-11 plasmacytoma cell line (Stanton et al. 1984) were maintained in RPMI1640 containing 10% fetal bovine serum, 2 mM glutamine and 50 mM 2-mercaptoethanol. The TEPC 1165 mouse plasmacytoma line (Yang et al. 1985) was obtained from Dr. R. Nordan (National Institutes of Health, Bethesda, MD) and was grown in the same media as above supplemented with 100 PCT-GF imits of recombinant 11-6 per milliliter of media (generous gift of R. Nordan). The mouse pre-B lymphocyte cell line 18-81 and the mouse L-cell fibroblast lines were cultured in Dulbecco's modified Eagle medium (DMEM) with 10% bovine calf serum and 2 mM glutamine.
TEPC 1165, MPC-11, 18-81, and L-cells were transiently transfected with HGH constructs by electroporation. Typically, 6x10^ cells in serum-free DMEM were electroporated with 4 jjcg of control plasmid, pCMVp-GAL, and 5-30 |xg of reporter HGH plasmid. Transfections with the VXl promoter constructs were done with less reporter DNA because of the considerable unenhanced activity of this promoter in some of the cell lines tested. Approximately 48 hr after electroporation, cell supematants were assayed for growth hormone content by use of the Allegro HGH transient gene expression system (Nichols Institute Diag nostics) following the manufacturer's protocol. At the same time, cell pellets were assayed for p-gal activity (Roederer et al. 1991) . HGH levels expressed by the various HS constructs were normalized for the ^-gal-determined transfection efficiencies, and relative transcription values were calculated relative to the enhancerless c-mycGH and VXIGH control plasmids. The data in Figure 4 are presented such that the activity of the enhancerless control (promoter only) is equal to 1.
Mouse plasmacytoma 1165 cells were stably transfected by electroporation of 10^ cells in serum-free DMEM with 5 |xg of linearized pRSV-Neo (Gorman et al. 1983 ) and 30 |xg of linear ized c-myc or HS1234 c-myc plasmid. Transfected cells were plated immediately into wells at low density to obtain clones following G418 selection (1.5 mg/ml for 2-4 weeks). Raji Burkitt's lymphoma cells were stably transfected with pHEBO de rived constructs by electroporating 10'' cells with 40 (xg of cir cular DNA. Stably transfected pools were established by selec tion in 1 mg/ml of hygromycin for 2 weeks.
DNA and RNA isolation and analyses
Total cellular DNA was isolated by standard techniques (Ausubel et al. 1989) , and copy numbers of transfected clones and pools were determined by Southern blot analyses of Xhol and Xbfll-digested DNA (1165 clones) or Xbal-digested DNA (Raji pools) with the 1113-bp Xhol-Xbal human c-myc fragment as a probe. Hybridization signals were quantitated with a Phosphorlmager system.
Total RNA for SI protection assays was isolated from cell clones and pools with RNAzol (Ciima/Biotecx) following the supplied protocol. 5'-End-labeled SI nuclease probes were gen erated by Sequenase (U.S. Biochemical) extension of phosphorylated oligonucleotides that previously had been annealed to single-stranded M13 c-myc templates. The double-stranded, ex tended DNA, was digested with Smal, and end-labeled singlestranded fragments were isolated on 6% acrylamide-urea gels. Oligonucleotides used as extension primers for human c-mycspecific probes included a 32-mer complementary to the c-myc coding strand from positions -1-270 to -1-302 relative to the PI initiation site (1165 clonal analysis) and a 22-mer complemen tary to sequences -t-505 to 4-527 relative to PI (Raji pools anal ysis).
The human GAPDH SI probe was generated by unidirec tional PCR on a linearized template by use of a phosphorylated primer complementary to GAPDH exon 1 sequences. Briefly, a plasmid containing the 548-bp Hindlll-Xbal fragment from hu man GAPDH exon 1 was restriction enzyme digested to create a linear template that contained 75 bp of vector sequence up stream of the GAPDH sequence. One hundred nanograms of a kinased 20-mer complementary to GAPDH sequences + 80 to -f-100 (relative to the HindlU site) and 5 jig of template DNA were heated to 94°C for 10 min and used in an eight-cycle PCR reaction. End-labeled single-stranded PCR products were puri fied on 6% acrylamide-urea gels. The mouse GAPDH SI probe was an end-labeled 73-base oligonucleotide that has a 60-base identity to the mouse GAPDH antisense strand.
SI assays were performed essentially as described (Spencer et al. 1990 ) with 40 |xg of total RNA and 1-5 x 10' to cpm of singlestranded probes. SI-Protected fragments were resolved on dena turing acrylamide-urea gels and signals were quantitated with a Phosphorlmager system. Total expression of c-myc constructs stably transfected into 1165 and Raji cells was calculated as the sum of PI-and P2-initiated transcripts normalized to the level of the GAPDH control transcripts.
Nuclear run-on assays
Isolation of nuclei and high salt (150 mM KCl ) nuclear run-on assays were performed as described (Bentley and Groudine 1986; Krumm et al. 1992) . [a-^^P]UTP-Labeled run-on transcrip tion products were column purified and hybridized to excess c-myc single-stranded antisense DNA that had been bound to GeneScreen Plus membranes. Filters were treated with RNase A and washed as described previously. Phosphorlmager quanti tated signals were corrected for the uridine content of the c-myc exon 1 probe (a 446-base Xhol-Pvull fragment containing 73 uridines that extends from -f-66 to -1-512) and the c-myc intron 1 probe (a 606-base Sad fragment with 136 uridines that extends from -1-940 to -I-1546). Nucleotide positions are given relative to the PI initiation site.
